A citation-based method for searching scientific literature

Fan Yu, Jianjiao Ni, Wanqin Zeng, Yue Zhou, Tiantian Guo, Ya Zeng, Yang Zhao, Shuyan Li, Yida Li, Xi Yang, Liqing Zou, Shengping Wang, Quan Liu, Yuan Li, Li Chu, Xiao Chu, Luxi Ye, Wen Yu, Zhengfei Zhu. Int J Radiat Oncol Biol Phys 2021
Times Cited: 9







List of co-cited articles
84 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
William J Magnuson, Nataniel H Lester-Coll, Abraham J Wu, T Jonathan Yang, Natalie A Lockney, Naamit K Gerber, Kathryn Beal, Arya Amini, Tejas Patil, Brian D Kavanagh,[...]. J Clin Oncol 2017
260
77

Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study.
S Gadgeel, S Peters, T Mok, A T Shaw, D W Kim, S I Ou, M Pérol, A Wrona, S Novello, R Rosell,[...]. Ann Oncol 2018
157
55

Osimertinib for Patients With Leptomeningeal Metastases Associated With EGFR T790M-Positive Advanced NSCLC: The AURA Leptomeningeal Metastases Analysis.
Myung-Ju Ahn, Chao-Hua Chiu, Ying Cheng, Ji-Youn Han, Sarah B Goldberg, Alastair Greystoke, Jeffrey Crawford, Yanqiu Zhao, Xiangning Huang, Martin Johnson,[...]. J Thorac Oncol 2020
47
55

CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3).
Yi-Long Wu, Myung-Ju Ahn, Marina Chiara Garassino, Ji-Youn Han, Nobuyuki Katakami, Hye Ryun Kim, Rachel Hodge, Paramjit Kaur, Andrew P Brown, Dana Ghiorghiu,[...]. J Clin Oncol 2018
233
55

Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases.
Eriko Miyawaki, Hirotsugu Kenmotsu, Keita Mori, Hideyuki Harada, Koichi Mitsuya, Nobuaki Mamesaya, Takahisa Kawamura, Haruki Kobayashi, Kazuhisa Nakashima, Shota Omori,[...]. Int J Radiat Oncol Biol Phys 2019
27
55

CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
Thanyanan Reungwetwattana, Kazuhiko Nakagawa, Byoung Chul Cho, Manuel Cobo, Eun Kyung Cho, Alessandro Bertolini, Sabine Bohnet, Caicun Zhou, Ki Hyeong Lee, Naoyuki Nogami,[...]. J Clin Oncol 2018
325
44

Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study.
James C H Yang, Sang-We Kim, Dong-Wan Kim, Jong-Seok Lee, Byoung Chul Cho, Jin-Seok Ahn, Dae H Lee, Tae Min Kim, Jonathan W Goldman, Ronald B Natale,[...]. J Clin Oncol 2020
127
44

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
Jean-Charles Soria, Yuichiro Ohe, Johan Vansteenkiste, Thanyanan Reungwetwattana, Busyamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata,[...]. N Engl J Med 2018
44

Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Linda Chen, Jacqueline Douglass, Lawrence Kleinberg, Xiaobu Ye, Ariel E Marciscano, Patrick M Forde, Julie Brahmer, Evan Lipson, William Sharfman, Hans Hammers,[...]. Int J Radiat Oncol Biol Phys 2018
178
33

Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis.
Kimberly L Johung, Norman Yeh, Neil B Desai, Terence M Williams, Tim Lautenschlaeger, Nils D Arvold, Matthew S Ning, Albert Attia, Christine M Lovly, Sarah Goldberg,[...]. J Clin Oncol 2016
239
33

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.
Paul W Sperduto, Norbert Kased, David Roberge, Zhiyuan Xu, Ryan Shanley, Xianghua Luo, Penny K Sneed, Samuel T Chao, Robert J Weil, John Suh,[...]. J Clin Oncol 2012
909
33

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.
Paul D Brown, Kurt Jaeckle, Karla V Ballman, Elana Farace, Jane H Cerhan, S Keith Anderson, Xiomara W Carrero, Fred G Barker, Richard Deming, Stuart H Burri,[...]. JAMA 2016
843
33

Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, Hubert Pan, Paul D Brown, Ananta Bangdiwala, Ryan Shanley, Norman Yeh, Laurie E Gaspar, Steve Braunstein,[...]. JAMA Oncol 2017
352
33

First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.
Jean-Charles Soria, Daniel S W Tan, Rita Chiari, Yi-Long Wu, Luis Paz-Ares, Juergen Wolf, Sarayut L Geater, Sergey Orlov, Diego Cortinovis, Chong-Jen Yu,[...]. Lancet 2017
657
33

Safety of Combined PD-1 Pathway Inhibition and Intracranial Radiation Therapy in Non-Small Cell Lung Cancer.
Harper G Hubbeling, Emily F Schapira, Nora K Horick, Kelly E H Goodwin, Jessica J Lin, Kevin S Oh, Alice T Shaw, William A Mehan, Helen A Shih, Justin F Gainor. J Thorac Oncol 2018
76
33

First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases.
Martin Schuler, Yi-Long Wu, Vera Hirsh, Kenneth O'Byrne, Nobuyuki Yamamoto, Tony Mok, Sanjay Popat, Lecia V Sequist, Dan Massey, Victoria Zazulina,[...]. J Thorac Oncol 2016
226
33

Leptomeningeal Metastases in Patients with NSCLC with EGFR Mutations.
Yang-Si Li, Ben-Yuan Jiang, Jin-Ji Yang, Hai-Yan Tu, Qing Zhou, Wei-Bang Guo, Hong-Hong Yan, Yi-Long Wu. J Thorac Oncol 2016
135
33

Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis.
Weiwei Yan, Yang Liu, Ji Li, Anqin Han, Li Kong, Jinming Yu, Hui Zhu. Radiat Oncol 2019
11
33

Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity.
Peter Ballard, James W T Yates, Zhenfan Yang, Dong-Wan Kim, James Chih-Hsin Yang, Mireille Cantarini, Kathryn Pickup, Angela Jordan, Mike Hickey, Matthew Grist,[...]. Clin Cancer Res 2016
420
33

EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases.
Tao Jiang, Chunxia Su, Xuefei Li, Chao Zhao, Fei Zhou, Shengxiang Ren, Caicun Zhou, Jun Zhang. J Thorac Oncol 2016
93
33

Efficacy of Alectinib in Patients with ALK-Positive NSCLC and Symptomatic or Large CNS Metastases.
Jessica J Lin, Ginger Y Jiang, Nencyben Joshipura, Jennifer Ackil, Subba R Digumarthy, Sandra P Rincon, Beow Y Yeap, Justin F Gainor, Alice T Shaw. J Thorac Oncol 2019
25
33


Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases.
Daniel B Costa, Alice T Shaw, Sai-Hong I Ou, Benjamin J Solomon, Gregory J Riely, Myung-Ju Ahn, Caicun Zhou, S Martin Shreeve, Paulina Selaru, Anna Polli,[...]. J Clin Oncol 2015
450
22

A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.
Paul W Sperduto, Brian Berkey, Laurie E Gaspar, Minesh Mehta, Walter Curran. Int J Radiat Oncol Biol Phys 2008
677
22

Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.
F J Lagerwaard, P C Levendag, P J Nowak, W M Eijkenboom, P E Hanssens, P I Schmitz. Int J Radiat Oncol Biol Phys 1999
522
22


Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Paul D Brown, Karla V Ballman, Jane H Cerhan, S Keith Anderson, Xiomara W Carrero, Anthony C Whitton, Jeffrey Greenspoon, Ian F Parney, Nadia N I Laack, Jonathan B Ashman,[...]. Lancet Oncol 2017
546
22

Stereotactic radiosurgery for four or more intracranial metastases.
Ajay K Bhatnagar, John C Flickinger, Douglas Kondziolka, L Dade Lunsford. Int J Radiat Oncol Biol Phys 2006
221
22

Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.
James W Welsh, Ritsuko Komaki, Arya Amini, Mark F Munsell, Wyatt Unger, Pamela K Allen, Joe Y Chang, Jeffrey S Wefel, Susan L McGovern, Linda L Garland,[...]. J Clin Oncol 2013
293
22

Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs.
E Felip, A T Shaw, A Bearz, D R Camidge, B J Solomon, J R Bauman, T M Bauer, S Peters, F Toffalorio, A Abbattista,[...]. Ann Oncol 2021
28
22

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.
David W Andrews, Charles B Scott, Paul W Sperduto, Adam E Flanders, Laurie E Gaspar, Michael C Schell, Maria Werner-Wasik, William Demas, Janice Ryu, Jean-Paul Bahary,[...]. Lancet 2004
22

Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study.
Masaaki Yamamoto, Toru Serizawa, Takashi Shuto, Atsuya Akabane, Yoshinori Higuchi, Jun Kawagishi, Kazuhiro Yamanaka, Yasunori Sato, Hidefumi Jokura, Shoji Yomo,[...]. Lancet Oncol 2014
777
22

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Eric L Chang, Jeffrey S Wefel, Kenneth R Hess, Pamela K Allen, Frederick F Lang, David G Kornguth, Rebecca B Arbuckle, J Michael Swint, Almon S Shiu, Moshe H Maor,[...]. Lancet Oncol 2009
22

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.
L Gaspar, C Scott, M Rotman, S Asbell, T Phillips, T Wasserman, W G McKenna, R Byhardt. Int J Radiat Oncol Biol Phys 1997
22

Non-small-cell Lung Cancer With Brain Metastasis at Presentation.
Saiama N Waqar, Pamela P Samson, Cliff G Robinson, Jeffrey Bradley, Siddhartha Devarakonda, Lingling Du, Ramaswamy Govindan, Feng Gao, Varun Puri, Daniel Morgensztern. Clin Lung Cancer 2018
81
22

Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
Justine L Kuiper, Lizza E Hendriks, Anthonie J van der Wekken, Adrianus J de Langen, Idris Bahce, Erik Thunnissen, Daniëlle A M Heideman, Yvonne Berk, Ed J M Buijs, Ernst-Jan M Speel,[...]. Lung Cancer 2015
69
22

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05.
E Shaw, C Scott, L Souhami, R Dinapoli, R Kline, J Loeffler, N Farnan. Int J Radiat Oncol Biol Phys 2000
22

Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
Jacob A Miller, Elizabeth E Bennett, Roy Xiao, Rupesh Kotecha, Samuel T Chao, Michael A Vogelbaum, Gene H Barnett, Lilyana Angelov, Erin S Murphy, Jennifer S Yu,[...]. Int J Radiat Oncol Biol Phys 2016
62
22

A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
Riccardo Soffietti, Martin Kocher, Ufuk M Abacioglu, Salvador Villa, François Fauchon, Brigitta G Baumert, Laura Fariselli, Tzahala Tzuk-Shina, Rolf-Dieter Kortmann, Christian Carrie,[...]. J Clin Oncol 2013
432
22

Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy.
Patrick G Morris, Anne S Reiner, Olga Rosenvald Szenberg, Jennifer L Clarke, Katherine S Panageas, Hector R Perez, Mark G Kris, Timothy A Chan, Lisa M DeAngelis, Antonio M Omuro. J Thorac Oncol 2012
163
22

EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours.
E Le Rhun, M Weller, D Brandsma, M Van den Bent, E de Azambuja, R Henriksson, T Boulanger, S Peters, C Watts, W Wick,[...]. Ann Oncol 2017
146
22


Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
Paul D Brown, Vinai Gondi, Stephanie Pugh, Wolfgang A Tome, Jeffrey S Wefel, Terri S Armstrong, Joseph A Bovi, Cliff Robinson, Andre Konski, Deepak Khuntia,[...]. J Clin Oncol 2020
276
22

Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases.
Kamran A Ahmed, Sungjune Kim, John Arrington, Arash O Naghavi, Thomas J Dilling, Ben C Creelan, Scott J Antonia, Jimmy J Caudell, Louis B Harrison, Solmaz Sahebjam,[...]. J Neurooncol 2017
83
22


Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG-0803).
Y-L Wu, C Zhou, Y Cheng, S Lu, G-Y Chen, C Huang, Y-S Huang, H-H Yan, S Ren, Y Liu,[...]. Ann Oncol 2013
185
22

EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours.
E Le Rhun, M Guckenberger, M Smits, R Dummer, T Bachelot, F Sahm, N Galldiks, E de Azambuja, A S Berghoff, P Metellus,[...]. Ann Oncol 2021
60
22

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
Tony S Mok, Yi-Long Wu, Myung-Ju Ahn, Marina C Garassino, Hye R Kim, Suresh S Ramalingam, Frances A Shepherd, Yong He, Hiroaki Akamatsu, Willemijn S M E Theelen,[...]. N Engl J Med 2017
22

Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy.
Yin-Duo Zeng, Hai Liao, Tao Qin, Li Zhang, Wei-Dong Wei, Jian-Zhong Liang, Fei Xu, Xiao-Xiao Dinglin, Shu-Xiang Ma, Li-Kun Chen. Oncotarget 2015
72
22

Osimertinib for EGFR-Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective Study.
Lijia Xie, Seema Nagpal, Heather A Wakelee, Gordon Li, Scott G Soltys, Joel W Neal. Oncologist 2019
19
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.